biontech

Pfizer moves to test COVID-19 vaccine for adolescents Pfizer announces promising results of the latest clinical study for the COVID-19 vaccine with 2,260 adolescent participants with 100% effective results on participants between the ages...

Advisory panel recommend FDA approval of Modern COVID-19 vaccine The FDA released an analysis of the data for the Moderna COVID-19 vaccine that supports the approval of the vaccine for emergency use. The next...

Medical expert committee to review BNT162b2 vaccine The coronavirus (COVID-19) vaccine created by U.S. pharmaceutical company Pfizer and German drugmaker Bio’N’Tech is set for a final review for emergency use by the FDA. If...

Pfizer and Bio’N’Tech will be the first to offer COVID-19 vaccine in the U.S. After months of research and rapid development, Pfizer and Bio’N’Tech secured authorization for emergency use from the FDA and CDC...

Pfizer and BioNTech planning for FDA approval for COVID-19 vaccine Pfizer and BioNTech apply for emergency use authorization of their potential coronavirus (COVID-19) vaccine with the FDA. The Food and Drug Administration will process...

Pfizer announces they’re closer to the COVID-19 vaccine The CEO of Pfizer, Albert Bourla, revealed the progress of producing a coronavirus (COVID-19) vaccine that is on track to be available to U.S. patients by...